Pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder
US9433596B2 · kind B2 · utility
0Cited by
0References
1Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 6, 2010 |
| Grant date | Sep 6, 2016 |
| Priority date | — |
| Expiry date | Aug 13, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/22
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates to a composition for treating anxiety disorder, particularly to a pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder such as post traumatic stress disorder or phobia. In accordance with the present disclosure, N-acetyl-L-cysteine can block the renewal of fear memories for a sustained period of time when it was administered during or after an exposure therapy to treat post traumatic stress disorder or phobia.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.